Capital Advantage, Inc. Mckesson Corp Transaction History

Capital Advantage, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$184.89 - $202.68 $563,914 - $618,174	-3,050 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$134.24 - $148.53 $939 - $1,039	-7 Reduced 0.23%	3,050 $417,000
Q1 2019 May 10, 2019	BUY	$111.86 - $136.3 $341,956 - $416,669	3,057 New	3,057 $358,000
Q4 2018 Feb 07, 2019	SELL	$108.23 - $136.84 $330,859 - $418,319	-3,057 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$135.02 - $162.6 $13,637 - $16,422	-101 Reduced 3.2%	3,057 $477,000

Q2 2017 Aug 08, 2017	BUY	N/A	3,158	3,158 $520,000

1,678

109M

676K

678K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $84.5B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital Advantage, Inc. with notifications on news.